Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2018 (2018), Article ID 9024034, 9 pages
https://doi.org/10.1155/2018/9024034
Research Article

6-Gingerol Activates PI3K/Akt and Inhibits Apoptosis to Attenuate Myocardial Ischemia/Reperfusion Injury

1Department of Cardiology, First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi Zhuang Autonomous Region 530021, China
2Department of Integrated Traditional Chinese and Western Medicine, First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541001, China
3Department of Respiratory, Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu 210029, China
4Department of Pharmacy, First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541001, China
5Department of Infectious Diseases, First Affiliated Hospital of Guilin Medical University, Guilin, Guangxi Zhuang Autonomous Region 541001, China

Correspondence should be addressed to Guoqiang Zhong; moc.621@gnohz_qg

Received 1 November 2017; Revised 25 January 2018; Accepted 11 February 2018; Published 20 March 2018

Academic Editor: Luciana Dini

Copyright © 2018 Xiangwei Lv et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. GBD 2013 Mortality and Causes of Death Collaborators, “Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013,” The Lancet, vol. 385, no. 9963, pp. 117–171, 2013. View at Google Scholar
  2. W. Chen, R. Gao, L. Liu et al., “Outline of the report on cardiovascular diseases in China, 2014,” European Heart Journal Supplements, vol. 18, pp. F2–F11, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. P. W. Armstrong, A. H. Gershlick, P. Goldstein et al., “Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction,” The New England Journal of Medicine, vol. 368, no. 15, pp. 1379–1387, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. P. Libby, “Mechanisms of acute coronary syndromes and their implications for therapy,” The New England Journal of Medicine, vol. 368, no. 21, pp. 2004–2013, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. E. C. Keeley, J. A. Boura, and C. L. Grines, “Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review of 23 randomised trials,” The Lancet, vol. 361, no. 9351, pp. 13–20, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Ghaderi, N. Alidadiani, N. Dilaver et al., “Role of glycogen synthase kinase following myocardial infarction and ischemia–reperfusion,” Apoptosis, vol. 22, no. 7, pp. 887–897, 2017. View at Publisher · View at Google Scholar · View at Scopus
  7. E. A. W. J. Dumont, L. Hofstra, W. L. Van Heerde et al., “Cardiomyocyte death induced by myocardial ischemia and reperfusion: Measurement with recombinant human annexin-V in a mouse model,” Circulation, vol. 102, no. 13, pp. 1564–1568, 2000. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Hofstra, I. H. Liem, E. A. Dumont et al., “Visualisation of cell death in vivo in patients with acute myocardial infarction,” The Lancet, vol. 356, no. 9225, pp. 209–212, 2000. View at Publisher · View at Google Scholar · View at Scopus
  9. X. Hu, C. Xu, X. Zhou, B. Cui, Z. Lu, and H. Jiang, “PI3K/Akt signaling pathway involved in cardioprotection of preconditioning with high mobility group box 1 protein during myocardial ischemia and reperfusion,” International Journal of Cardiology, vol. 150, no. 2, pp. 222-223, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. T. Ha, F. Hua, X. Liu et al., “Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism,” Cardiovascular Research, vol. 78, no. 3, pp. 546–553, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. Y. Fujio, T. Nguyen, D. Wencker, R. N. Kitsis, and K. Walsh, “Akt promotes survival of cardiomyocytes in vitro and protects against lschemia-reperfusion injury in mouse heart,” Circulation, vol. 101, no. 6, pp. 660–667, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Negoro, H. Oh, E. Tone et al., “Glycoprotein 130 regulates cardiac myocyte survival in doxorubicin-induced apoptosis through phosphatidylinositol 3-kinase/Akt phosphorylation and Bcl-xL/caspase-3 interaction,” Circulation, vol. 103, no. 4, pp. 555–561, 2001. View at Publisher · View at Google Scholar · View at Scopus
  13. Y.-Q. Jiang, G.-L. Chang, Y. Wang, D.-Y. Zhang, L. Cao, and J. Liu, “Geniposide Prevents Hypoxia/Reoxygenation-Induced Apoptosis in H9c2 Cells: Improvement of Mitochondrial Dysfunction and Activation of GLP-1R and the PI3K/AKT Signaling Pathway,” Cellular Physiology and Biochemistry, vol. 39, no. 1, pp. 407–421, 2016. View at Publisher · View at Google Scholar · View at Scopus
  14. Y. Sun, C. Jiang, J. Jiang, and L. Qiu, “Dexmedetomidine protects mice against myocardium ischaemic/reperfusion injury by activating an AMPK/PI3K/Akt/eNOS pathway,” Clinical and Experimental Pharmacology and Physiology, vol. 44, no. 9, pp. 946–953, 2017. View at Publisher · View at Google Scholar · View at Scopus
  15. C.-W. Liu, F. Yang, S.-Z. Cheng, Y. Liu, L.-H. Wan, and H.-L. Cong, “Rosuvastatin postconditioning protects isolated hearts against ischemia–reperfusion injury: The role of radical oxygen species, PI3K–Akt–GSK-3β pathway, and mitochondrial permeability transition pore,” Cardiovascular Therapeutics, vol. 35, no. 1, pp. 3–9, 2017. View at Publisher · View at Google Scholar · View at Scopus
  16. P. J. Mink, C. G. Scrafford, L. M. Barraj et al., “Flavonoid intake and cardiovascular disease mortality: A prospective study in postmenopausal women,” American Journal of Clinical Nutrition, vol. 85, no. 3, pp. 895–909, 2007. View at Publisher · View at Google Scholar · View at Scopus
  17. H.-J. Wu, J.-Y. Yang, M. Jin et al., “Glycyrrhetinic acid protects the heart from ischemia/reperfusion injury by attenuating the susceptibility and incidence of fatal ventricular arrhythmia during the reperfusion period in the rat hearts,” Cellular Physiology and Biochemistry, vol. 36, no. 2, pp. 741–752, 2015. View at Publisher · View at Google Scholar · View at Scopus
  18. J. Krell and J. Stebbing, “Ginger: The root of cancer therapy?” The Lancet Oncology, vol. 13, no. 3, pp. 235-236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Li, B. Xu, and M. Xu, “6-Gingerol protects intestinal barrier from ischemia/reperfusion-induced damage via inhibition of p38 MAPK to NF-κB signalling,” Pharmacological Research, vol. 119, pp. 137–148, 2017. View at Publisher · View at Google Scholar
  20. C. Sampath, S. Sang, and M. Ahmedna, “In vitro and in vivo inhibition of aldose reductase and advanced glycation end products by phloretin, epigallocatechin 3-gallate and [6]-gingerol,” Biomedicine & Pharmacotherapy, vol. 84, pp. 502–513, 2016. View at Publisher · View at Google Scholar · View at Scopus
  21. W. M. El-Bakly, M. L. Louka, A. M. El-Halawany, and M. F. Schaalan, “6-Gingerol ameliorated doxorubicin-induced cardiotoxicity: role of nuclear factor kappa B and protein glycation,” Cancer Chemotherapy and Pharmacology, vol. 70, no. 6, pp. 833–841, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. X. Lv and T. Xu, “6-Gingerol inhibits oxidative stress ameliorated myocardial ischemia/reperfusion injury in rats,” Journal of Clinical Cardiology (China), vol. 33, pp. 575–579, 2017, (In Chinese with English abstract). View at Google Scholar
  23. R. Aneja, P. W. Hake, T. J. Burroughs, A. G. Denenberg, H. R. Wong, and B. Zingarelli, “Epigallocatechin, a green tea polyphenol, attenuates myocardial ischemia reperfusion injury in rats,” Molecular Medicine, vol. 10, no. 1-6, pp. 55–62, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Li, X. Hu, J. Wang et al., “Short-Term Hesperidin Pretreatment Attenuates Rat Myocardial Ischemia/Reperfusion Injury by Inhibiting High Mobility Group Box 1 Protein Expression via the PI3K/Akt Pathway,” Cellular Physiology and Biochemistry, vol. 39, no. 5, pp. 1850–1862, 2016. View at Publisher · View at Google Scholar · View at Scopus
  25. D. M. Yellon and D. J. Hausenloy, “Myocardial reperfusion injury,” The New England Journal of Medicine, vol. 357, no. 11, pp. 1074–1135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  26. D. S. Burley, P. Ferdinandy, and G. F. Baxter, “Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling,” British Journal of Pharmacology, vol. 152, no. 6, pp. 855–869, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. H. Fliss and D. Gattinger, “Apoptosis in ischemic and reperfused rat myocardium,” Circulation Research, vol. 79, no. 5, pp. 949–956, 1996. View at Publisher · View at Google Scholar · View at Scopus
  28. Z.-Q. Zhao, M. Nakamura, N.-P. Wang et al., “Reperfusion induces myocardial apoptotic cell death,” Cardiovascular Research, vol. 45, no. 3, pp. 651–660, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Xu, D. Li, and D. Jiang, “Targeting cell signaling and apoptotic pathways by luteolin: cardioprotective role in rat cardiomyocytes following ischemia/reperfusion,” Nutrients, vol. 4, no. 12, pp. 2008–2019, 2012. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Olivetti, F. Quaini, R. Sala et al., “Acute myocardial infarction in humans is associated with activation of programmed myocyte cell death in the surviving portion of the heart,” Journal of Molecular and Cellular Cardiology, vol. 28, no. 9, pp. 2005–2016, 1996. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Kim, N.-H. Yim, and J. Y. Ma, “Samsoeum, a traditional herbal medicine, elicits apoptotic and autophagic cell death by inhibiting Akt/mTOR and activating the JNK pathway in cancer cells,” BMC Complementary and Alternative Medicine, vol. 13, article 233, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Zhai, B. Li, W. Duan et al., “Melatonin ameliorates myocardial ischemia reperfusion injury through SIRT3-dependent regulation of oxidative stress and apoptosis,” Journal of Pineal Research, vol. 63, no. 2, Article ID e12419, 2017. View at Publisher · View at Google Scholar · View at Scopus
  33. H.-F. Pei, J.-N. Hou, F.-P. Wei et al., “Melatonin attenuates postmyocardial infarction injury via increasing Tom70 expression,” Journal of Pineal Research, vol. 62, no. 1, Article ID e12371, 2017. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Bae, M. Park, C. Kang et al., “Hydrogen Peroxide‐Responsive Nanoparticle Reduces Myocardial Ischemia/Reperfusion Injury,” Journal of the American Heart Association, vol. 5, no. 11, 2016. View at Publisher · View at Google Scholar
  35. W. Zhang, Z. Sun, and F. Meng, “Schisandrin B Ameliorates Myocardial Ischemia/Reperfusion Injury Through Attenuation of Endoplasmic Reticulum Stress-Induced Apoptosis,” Inflammation, pp. 1–9, 2017. View at Publisher · View at Google Scholar · View at Scopus
  36. H. K. Siddall, C. E. Warrell, D. M. Yellon, and M. M. Mocanu, “Ischemia-reperfusion injury and cardioprotection: Investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency,” Basic Research in Cardiology, vol. 103, no. 6, pp. 560–568, 2008. View at Publisher · View at Google Scholar · View at Scopus
  37. F. Damilano, A. Perino, and E. Hirsch, “PI3k kinase and scaffold functions in heart,” Annals of the New York Academy of Sciences, vol. 1188, pp. 39–45, 2010. View at Publisher · View at Google Scholar · View at Scopus
  38. W. Hu, P. Zhang, J. Gu, Q. Yu, and D. Zhang, “NEDD4-1 protects against ischaemia/reperfusion-induced cardiomyocyte apoptosis via the PI3K/Akt pathway,” Apoptosis, vol. 22, no. 3, pp. 437–448, 2017. View at Publisher · View at Google Scholar · View at Scopus
  39. X. Wang, T. Ha, Y. Hu et al., “MicroRNA-214 protects against hypoxia/reoxygenation induced cell damage and myocardial ischemia/reperfusion injury via suppression of PTEN and Bim1 expression,” Oncotarget , vol. 7, no. 52, pp. 86926–86936, 2016. View at Publisher · View at Google Scholar · View at Scopus
  40. H. Yu, H. Zhang, W. Zhao et al., “Gypenoside Protects against Myocardial Ischemia-Reperfusion Injury by Inhibiting Cardiomyocytes Apoptosis via Inhibition of CHOP Pathway and Activation of PI3K/Akt Pathway in Vivo and in Vitro,” Cellular Physiology and Biochemistry, vol. 39, no. 1, pp. 123–136, 2016. View at Publisher · View at Google Scholar · View at Scopus